ArticleSTAR protocols2022

Protocol for evaluating antitumor activity of KIR3DL3 blockade in an NK cell-based xenogeneic lung tumor model.

Xiaoxin Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.